Epidemiology of sarcoidosis: recent advances and future prospects.
about
Granuloma formation in pulmonary sarcoidosisEpidemiology of uveitis in the mid-Atlantic United States.Hepatosplenic sarcoidosis: contrast-enhanced ultrasound findings and implications for clinical practice.Sarcoidosis--scientific progress and clinical challenges.Prospective risk of cancer and the influence of tobacco use in carriers of the p16-Leiden germline variant.Immune mediated diseases and immune modulation in the neurocritical care unitEpidemiological, Clinical, and Paraclinic Aspect of Cutaneous Sarcoidosis in Black Africans.Circulating cytokines in sarcoidosis: phenotype-specific alterations for fibrotic and non-fibrotic pulmonary disease.Childhood sarcoidosis: A rare but fascinating disorder.Role of interleukin 4 and its receptor in clinical presentation of chronic extrinsic allergic alveolitis: a pilot studyPrevalence of cardiac sarcoidosis in white population: a case-control study: Proposal for a novel risk index based on commonly available testsT cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis.Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[18F]fluoro-D-glucose positron emission and computed tomography.The impact of ACE gene polymorphism on the incidence and phenotype of sarcoidosis in rural and urban settings.Review series: Aspects of interstitial lung disease. Sarcoidosis.Long-term treatment with infliximab in patients with sarcoidosis.MRI in transverse myelitis.Interleukin-12 family cytokines and sarcoidosis.Challenges in the diagnosis and treatment of neurosarcoidosis.Sarcoidosis: an update on current pharmacotherapy options and future directions.Frequency of IWOS Suggestive Ocular Signs in Slovenian Uveitis Patients with Confirmed Pulmonary Sarcoidosis.A conceptual model of health-related quality of life in sarcoidosis.Development and testing of item response theory-based item banks and short forms for eye, skin and lung problems in sarcoidosis.Presentations and outcomes of neurosarcoidosis: a study of 54 cases.Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series.
P2860
Q26863703-F0C12325-3AD4-4E72-8E25-691FA1B85BDCQ30279210-025A6391-5BA3-4B48-A7D6-C9CD00350EB1Q34120732-FC6BD885-FAF3-4EF8-AA84-29E9B0DB7AECQ34199947-7DD2E4A7-71B5-4769-92B8-EFCDB1F06E26Q35478014-E2F390C7-EFF6-42E1-832A-30E7E0E3CF0FQ35729575-277B390D-DECE-4F5E-BF1B-62615C58366EQ36304576-BB74156E-80F3-4E9C-8718-B9783257CEDCQ36738614-750E324D-6FD7-4E71-945F-54139E53A591Q36919800-CA90FE73-CFBE-4118-94BF-AAA4958DCD06Q36929895-293DDFE8-9D7A-4E5A-9423-3377F83231A0Q37176025-0FDCF7A7-4641-43FF-8D22-EE8E38ECD3C7Q37237394-ECB9C285-0CCF-42A5-AC41-7CBCAAB031FFQ37322344-0B31E20B-FD0C-4985-B41F-91E0444935C0Q37412625-F06C07F0-68DD-447C-BF8D-5209D4E10E57Q37810386-6AFD7F8C-D064-48EC-9A7A-A4C9BAB765AAQ37910659-7FF82402-D874-4061-AB53-7A9B01250CC5Q38206160-1D9E3942-4889-4CF1-8B85-090E445FAEC6Q38266881-B1125E4A-2F4A-44CC-ACDF-3F7CFB1FFA92Q38607759-14A12F76-70FC-414C-894A-B75B9CE28FAEQ38798146-27572E92-1242-4A9D-8242-01B8EB9A5454Q40233635-5C287249-AE31-4410-A09E-B1248DF39E71Q45378538-6C6A2606-603D-40BD-A379-61C6D4E3E74CQ45726271-46A1FC4D-6D6E-4150-9E6C-71C3D39CCE97Q46042039-4F43981A-622D-44E5-A1E8-DEAE5F2B3FBEQ46271418-D1C4C2DC-F2D1-4416-80EA-33978BCB4B94
P2860
Epidemiology of sarcoidosis: recent advances and future prospects.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Epidemiology of sarcoidosis: recent advances and future prospects.
@en
type
label
Epidemiology of sarcoidosis: recent advances and future prospects.
@en
prefLabel
Epidemiology of sarcoidosis: recent advances and future prospects.
@en
P356
P1476
Epidemiology of sarcoidosis: recent advances and future prospects.
@en
P2093
Benjamin A Rybicki
Michael C Iannuzzi
P356
10.1055/S-2007-970331
P577
2007-02-01T00:00:00Z